Ashraf Z. Badros, MB, ChB, discusses the next steps following the phase 3 AURIGA trial of daratumumab and lenalidomide vs lenalidomide maintenance in patients with newly diagnosed multiple myeloma.

Erez Israeli, Chief Executive Officer of Dr. Reddy’s, said: “We are pleased to collaborate with Henlius to make this daratumumab biosimilar available to patients in the U.S. and Europe.

That's where shoe inserts can offer additional support, says Kate Macfarlane, a certified running, fitness, and endurance coach. "They are typically used by runners requiring help to address ...

"Millions of packages moved away from SurePost and the United States Postal Service and returned to UPS package cars this month, now being sorted and delivered by hardworking UPS Teamsters." ...

but one of the conclusions of the pilot was that a pre-requisite for adoption will be "robust systems in place ensuring that the patient can easily access the package leaflet for their medicine in ...

Daratumumab, which traditionally has been used in later stages of treatment for multiple myeloma, is now believed to be effective when added to upfront treatments Using daratumumab right away can be ...

Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his abdomen after drinking water. It was just a fleeting moment; one he ...

2 In this letter, we report the successful treatment of an ECMO-dependent case of anti-MDA5-associated ARDS with the anti-CD38 monoclonal antibody daratumumab. The 55-year-old female patient was ...

Daratumumab is under clinical development by Johnson & Johnson and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase II drugs for Systemic Lupus Erythematosus have ...